IL79672A - Process for the preparation of crystalline torasemide of pure modification i,and pharmaceutical compositions containing it - Google Patents

Process for the preparation of crystalline torasemide of pure modification i,and pharmaceutical compositions containing it

Info

Publication number
IL79672A
IL79672A IL79672A IL7967286A IL79672A IL 79672 A IL79672 A IL 79672A IL 79672 A IL79672 A IL 79672A IL 7967286 A IL7967286 A IL 7967286A IL 79672 A IL79672 A IL 79672A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
pure modification
torasemide
Prior art date
Application number
IL79672A
Other languages
English (en)
Other versions
IL79672A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL79672A0 publication Critical patent/IL79672A0/xx
Publication of IL79672A publication Critical patent/IL79672A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL79672A 1985-08-17 1986-08-10 Process for the preparation of crystalline torasemide of pure modification i,and pharmaceutical compositions containing it IL79672A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853529529 DE3529529A1 (de) 1985-08-17 1985-08-17 Verfahren zur herstellung einer stabilen modifikation von torasemid

Publications (2)

Publication Number Publication Date
IL79672A0 IL79672A0 (en) 1986-11-30
IL79672A true IL79672A (en) 1990-01-18

Family

ID=6278766

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79672A IL79672A (en) 1985-08-17 1986-08-10 Process for the preparation of crystalline torasemide of pure modification i,and pharmaceutical compositions containing it

Country Status (25)

Country Link
US (4) US4743693A (sh)
EP (1) EP0212537B1 (sh)
JP (2) JPS6245576A (sh)
KR (1) KR930009818B1 (sh)
AU (1) AU573454B2 (sh)
CA (1) CA1307277C (sh)
CS (2) CS259891B2 (sh)
DD (1) DD259858A5 (sh)
DE (2) DE3529529A1 (sh)
DK (1) DK162518C (sh)
ES (1) ES2001522A6 (sh)
FI (1) FI82189C (sh)
GR (1) GR862139B (sh)
HK (1) HK59994A (sh)
HU (1) HU195778B (sh)
IE (1) IE59237B1 (sh)
IL (1) IL79672A (sh)
LT (1) LT3596B (sh)
NO (1) NO170079C (sh)
NZ (1) NZ217172A (sh)
PL (1) PL146086B1 (sh)
PT (1) PT83186B (sh)
SU (1) SU1480766A3 (sh)
UA (1) UA7080A1 (sh)
ZA (1) ZA866151B (sh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
HRP980532B1 (en) * 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US5914336A (en) 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
US6166045A (en) 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
SI20816A (sl) * 1999-08-11 2002-08-31 Teva Pharmaceutical Industries Ltd. Polimorfi torsemid-a
CA2410802A1 (en) * 2000-02-17 2002-09-06 Minutza Leibovici A stable pharmaceutical formulation comprising torsemide modification ii
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
WO2001070226A1 (en) 2000-03-20 2001-09-27 Teva Pharmaceutical Industries Ltd. Novel processes for preparing torsemide intermediate
HRP20000765A2 (en) * 2000-11-10 2002-06-30 Pliva D D Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
IN192178B (sh) * 2001-08-03 2004-03-06 Ranbaxy Lab
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
ITMI20020639A1 (it) * 2002-03-27 2003-09-29 Cosma S P A Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
PT1465890E (pt) * 2002-11-18 2007-05-31 Teva Pharma Lansoprazole estável contendo mais de 500 ppm, até cerca de 3000 ppm de água e mais de 200 ppm, até cerca de 5000 de álcool
WO2004072061A1 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
AT500576B1 (de) * 2004-07-28 2006-11-15 Sanochemia Pharmazeutika Ag Verfahren zur reindarstellung von kristallformen von torsemid
US10178893B1 (en) * 2013-06-14 2019-01-15 Scott Bradley Baker Shoe
FR3018688A1 (fr) * 2014-03-19 2015-09-25 Virbac Utilisation de torasemide a faible dose dans une composition veterinaire
EP3031471A1 (en) * 2014-12-12 2016-06-15 Ceva Sante Animale Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals
US12048677B2 (en) 2014-12-12 2024-07-30 Ceva Sante Animale Compositions and uses thereof for the treatment of heart failure in domestic animals
PL3173075T3 (pl) * 2015-11-27 2019-04-30 Accupharma Spolka Z Ograniczona Odpowiedzialnoscia Farmaceutyczny preparat złożony inhibitora ACE i diuretyku pętlowego
CN115417810B (zh) * 2022-09-22 2023-10-10 南京正科医药股份有限公司 一种托拉塞米晶型ⅰ的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30633A (en) * 1860-11-13 Improvement in fire-escapes
GB1477664A (en) 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
LU85193A1 (fr) * 1984-01-31 1985-09-12 Christiaens Sa A Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation

Also Published As

Publication number Publication date
LT3596B (en) 1995-12-27
UA7080A1 (uk) 1995-06-30
USRE34672E (en) 1994-07-26
NO863305L (no) 1987-02-18
JPH02191255A (ja) 1990-07-27
DD259858A5 (de) 1988-09-07
NO863305D0 (no) 1986-08-15
PL261052A1 (en) 1987-11-02
IL79672A0 (en) 1986-11-30
DK162518B (da) 1991-11-11
IE862179L (en) 1987-02-17
DK162518C (da) 1992-03-30
PT83186B (pt) 1988-07-01
HUT42069A (en) 1987-06-29
USRE34580E (en) 1994-04-05
FI863305A0 (fi) 1986-08-15
GR862139B (en) 1986-12-30
CS259891B2 (en) 1988-11-15
KR870002076A (ko) 1987-03-30
KR930009818B1 (ko) 1993-10-11
DK385586D0 (da) 1986-08-13
HU195778B (en) 1988-07-28
ES2001522A6 (es) 1988-06-01
IE59237B1 (en) 1994-01-26
CA1307277C (en) 1992-09-08
EP0212537A1 (de) 1987-03-04
JPH0415205B2 (sh) 1992-03-17
DE3529529A1 (de) 1987-02-19
PT83186A (de) 1986-09-01
DE3667970D1 (de) 1990-02-08
DE3529529C2 (sh) 1987-05-27
NZ217172A (en) 1989-02-24
JPS6245576A (ja) 1987-02-27
AU6105586A (en) 1987-02-19
JPH0643400B2 (ja) 1994-06-08
FI82189B (fi) 1990-10-31
ZA866151B (en) 1987-04-29
DK385586A (da) 1987-02-18
HK59994A (en) 1994-07-08
PL146086B1 (en) 1988-12-31
AU573454B2 (en) 1988-06-09
NO170079C (no) 1992-09-09
CS594586A2 (en) 1988-03-15
CS419991A3 (en) 1992-06-17
NO170079B (no) 1992-06-01
EP0212537B1 (de) 1990-01-03
FI82189C (fi) 1991-02-11
FI863305A (fi) 1987-02-18
SU1480766A3 (ru) 1989-05-15
LTIP898A (en) 1995-03-27
US4743693A (en) 1988-05-10
US4822807A (en) 1989-04-18

Similar Documents

Publication Publication Date Title
IL79672A (en) Process for the preparation of crystalline torasemide of pure modification i,and pharmaceutical compositions containing it
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
DE3666036D1 (en) Phenylethanol aminotetralines, process for their preparation and pharmaceutical compositions containing them
PT84936A (en) Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
PT85329A (en) Process for the preparation of tetrahydronaphtaline and indane derivatives and of pharmaceutical compositions containing the same
PT83594A (en) Process for preparation of insecticidal n:-substituted-n,n:-diacyllhydrazines and of insecticidal compositions containing the same
PT86365A (en) Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same
PT83260A (en) Process for the preparation of spergualin telated compounds and of pharmaceutical compositions containing them
PT84358A (en) Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same
EP0302792A3 (en) Alkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
PT81502A (en) Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same
IL80394A0 (en) Antihypertensive thieno-isoxazoles and thieno-pyrazoles,process for their preparation and pharmaceutical compositions containing them
PT84923A (en) Process for the preparation of 1-(hydroxystyrul)-5h-2,3-benzodiapezine derivatives and pharmaceutical compositions containing the same
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
PT85337A (en) Process for the preparation of cycloalkyl-substituted 4-pyridil derivatives and of pharmaceutical compositions containing the same
PT83565A (en) Process for the preparation of acid aryl-heterocyclic-alcoxi-acetic derivatives and of pharmaceutical compositions containing same
PT81954A (en) Process for the preparation of pharmaceutical compositions containing 9,10-dihydro alkalloids of ergot
PT82464A (en) Process for the preparation of novel benzisoselenazolonyl derivatives and of pharmaceutical compositions containing the same
EP0220653A3 (en) 3-aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds, process for preparation and use thereof, and pharmaceutical composition containing the same
ZA864504B (en) Derivatives of 2-fluoroalkylbenzimidazole,process for their preparation and pharmaceutical compositions containing them
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
PT81083A (en) Process for the preparation of substituted 7-oxomitosanes and of pharmaceutical compositions containing the same
PT83984A (en) Process for the preparation of novel 16,17-acetalsubstituted pregnane 21-oic derivatives and of pharmaceutical compositions containing the same
PT83232A (en) Process for the preparation of gem-dihalo-and tetrahalo-1,12-diamino-4,9-diaza-dodecanes and of pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired